Anti-C5a antibody [EPR24303-10]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal C5 antibody. Suitable for IP, WB, IHC-P, Flow Cyt (Intra) and reacts with Human samples. Cited in 3 publications.
View Alternative Names
CPAMD4, C5, Complement C5, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-C5a antibody [EPR24303-10] (AB281923)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HEK-293 (Human embryonic kidney epithelial cell, Left)/ HepG2 (human hepatocellular carcinoma epithelial cell, Right) cells labelling C5a with ab281923 at 1/50 dilution (1ug)/ (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody. No expression was observed in cell line : HEK-293.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C5a antibody [EPR24303-10] (AB281923)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labelling C5a with ab281923 at 1/500 dilution (1.092 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on plasma of human colon. The section was incubated with ab281923 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C5a antibody [EPR24303-10] (AB281923)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labelling C5a with ab281923 at 1/500 dilution (1.092 ug/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Positive staining on human liver. The section was incubated with ab281923 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IP
Supplier Data
Immunoprecipitation - Anti-C5a antibody [EPR24303-10] (AB281923)
C5a was immunoprecipitated from 0.35 mg Human plasma with ab281923 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab281923 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Human plasma 10 μL
Lane 2 : ab281923 IP in Human plasma
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab281923 in human plasma
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 6 seconds.
All lanes:
Immunoprecipitation - Anti-C5a antibody [EPR24303-10] (ab281923)
Observed band size: 110 kDa
false
- WB
Lab
Western blot - Anti-C5a antibody [EPR24303-10] (AB281923)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
110 kDa Complement C5 alpha chain is observed. The molecular weight is consistent with what has been described in the literature (PMID : 24071736, 23401592, 25387724).
Very low or no expression of C5 alpha chain is observed in testis, skeletal muscle.
Exposure time : 6 seconds.
All lanes:
Western blot - Anti-C5a antibody [EPR24303-10] (ab281923) at 1/1000 dilution
Lane 1:
Human plasma at 10 µL
Lane 2:
Human testis tissue lysate at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/1000 dilution
Observed band size: 110 kDa
false
- WB
Lab
Western blot - Anti-C5a antibody [EPR24303-10] (AB281923)
Western blot : Rabbit monoclonal [EPR24303-10] to C5a ab281923 staining at 1/1000 dilution, shown in green; Mouse anti-CANX (ab238078) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 180 kDa in Wild-type A549 cell lysates with no signal observed at this size in C5 knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-C5a antibody [EPR24303-10] (ab281923) at 1/1000 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
C5 knockout A549 at 20 µg
Lane 3:
HepG2 at 20 µg
Lane 4:
U-2 OS at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 188 kDa
Observed band size: 180 kDa
false
Related conjugates and formulations (1)
-
Anti-C5a antibody [EPR24303-10] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C5a functions as part of the complement cascade a complex series of events essential for opsonization cell lysis and inflammation. C5a binds to its receptors initiating cell responses such as chemotaxis increased vascular permeability and release of pro-inflammatory cytokines. These processes help in pathogen clearance making C5a a significant player in innate immunity. C5a exists as part of the larger complement system that includes proteins like C3 and C5 forming an important arm of the body's defense against pathogens.
Pathways
C5a integrates into the complement pathway and the coagulation cascade. It drives actions in the inflammatory response enhancing immune defense by promoting cytokine production and leukocyte migration. Important interactions occur with complement proteins such as C3 and C5b-9 key elements of the terminal complement complex. By influencing these pathways C5a directly contributes to both immune modulation and inflammatory processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Communications biology 8:879 PubMed40481230
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and experimental medicine 24:139 PubMed38951265
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2302613 PubMed37345586
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com